Published online before print August 21, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
*The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA; and
Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, Maryland, USA
@ To whom correspondence should be addressed. E-mail: ascott{at}jhsph.edu.
Most of our understanding of the development and phenotype of alternatively activated macrophages (AAMs) has been obtained from studies investigating the response of bone marrow- and peritoneal-derived cells to IL-4 or IL-13 stimulation. Comparatively little is known about the development of AAMs in the lungs, and how the complex signals associated with pulmonary inflammation influence the AAM phenotype. Here, we use Nippostrongylus brasiliensis to initiate AAM development and define the dynamics of surface molecules, gene expression, and cell function of macrophages isolated from lung tissue at different times postinfection (PI). Initially, lung macrophages take on a foamy phenotype, up-regulate MHC and costimulatory molecules, express reduced levels of TNF and IL-12, and undergo proliferation. Cells isolated between Days 8 and 15 PI adopt a dense, granular phenotype and exhibit reduced levels of costimulatory molecules and elevated levels of programmed death ligand-1 (PDL-1) and PDL-2 and an increase in IL-10 expression. Functionally, AAMs isolated on Days 13–15 PI demonstrate an enhanced capacity to take up and sequester antigen. However, these same cells did not mediate antigen-specific T cell proliferation and dampened the proliferation of CD3/CD28-activated CD4+ T cells. These data indicate that the AAM in the lungs, although initiated by IL-4/IL-13, is a dynamic process that is likely to be influenced by other immune and nonimmune factors in the pulmonary environment.
Key Words: nematode hygiene hypothesis pulmonary alternatively activated arginase YM1 FIZZ1
This article has been cited by other articles:
![]() |
S. Donnelly, S. M. O'Neill, C. M. Stack, M. W. Robinson, L. Turnbull, C. Whitchurch, and J. P. Dalton Helminth Cysteine Proteases Inhibit TRIF-dependent Activation of Macrophages via Degradation of TLR3 J. Biol. Chem., January 29, 2010; 285(5): 3383 - 3392. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Azevedo Sias, R. Oliveira Caetano, J. Dutra Comarella, E. de Oliveira, A. Santos Ferreira, and T. Quirico-Santos Successful treatment of lipoid pneumonia associated with bowel obstruction by Ascaris lumbricoides J Trop Pediatr, December 21, 2009; (2009) fmp119v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Nair, Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung J. Exp. Med., April 13, 2009; 206(4): 937 - 952. [Abstract] [Full Text] [PDF] |
||||